Alcon, Inc.
Alcon Receives FDA Approval of TRIESENCE(TM) Injectable Triamcinolone Suspension for Use in Eye Surgery
Published in FDA Law Weekly, December 20th, 2007
The active ingredient in TRIESENCE(TM), triamcinolone acetonide, has been used for many years to treat retinal disease. This new approval brings ophthalmologists a sterile, preservative-free formulation of the compound specifically developed for use in the eye to treat various...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly
Source: FDA Law Weekly (2007-12-20)
More Articles from FDA Law Weekly
- Biomedicine
California Healthcare Institute Urges Congress to Extend R&D Tax Credit - Campaign for Tobacco-Free Kids
New Report: Tobacco Regulation Would Save Utah $178 Million in Health Care Costs by Preventing 10,200 Kids From Smoking - Campaign for Tobacco-Free Kids
New Report: Tobacco Regulation Would Save Virginia $1 Billion in Health Care Costs by Preventing 59,300 Kids from Smoking - MedcomSoft Inc.
MedcomSoft appoints former U.S. presidential health advisor, James Haveman, to health Care advisory board - Regulatory Actions
Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lexapro(R) - The 60 Plus Association
Leader Urges Congress Not to Worsen FDA Crisis - More from this issue of FDA Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
